276 related articles for article (PubMed ID: 22750290)
21. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
22. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.
Mazzacurati L; Lambert QT; Pradhan A; Griner LN; Huszar D; Reuther GW
Oncotarget; 2015 Nov; 6(37):40141-57. PubMed ID: 26472029
[TBL] [Abstract][Full Text] [Related]
23. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.
Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K
Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044
[TBL] [Abstract][Full Text] [Related]
24. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
Beales IL; Ogunwobi O
Mol Cell Endocrinol; 2006 Mar; 247(1-2):140-9. PubMed ID: 16442704
[TBL] [Abstract][Full Text] [Related]
25. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade.
Zhou G; Golden T; Aragon IV; Honkanen RE
J Biol Chem; 2004 Nov; 279(45):46595-605. PubMed ID: 15328343
[TBL] [Abstract][Full Text] [Related]
26. RACK1 mediates activation of JNK by protein kinase C [corrected].
López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
[TBL] [Abstract][Full Text] [Related]
27. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner.
Zhang R; Al-Lamki R; Bai L; Streb JW; Miano JM; Bradley J; Min W
Circ Res; 2004 Jun; 94(11):1483-91. PubMed ID: 15117824
[TBL] [Abstract][Full Text] [Related]
28. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway.
Nakajima A; Komazawa-Sakon S; Takekawa M; Sasazuki T; Yeh WC; Yagita H; Okumura K; Nakano H
EMBO J; 2006 Nov; 25(23):5549-59. PubMed ID: 17110930
[TBL] [Abstract][Full Text] [Related]
29. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the mechanism of polycythemia vera by studying JAK2 mutant-induced signaling pathway].
Funakoshi-Tago M
Yakugaku Zasshi; 2011; 131(8):1183-7. PubMed ID: 21804321
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
32. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
[TBL] [Abstract][Full Text] [Related]
33. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
Shen K; Ji L; Lu B; Wang Z
Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
[TBL] [Abstract][Full Text] [Related]
34. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
35. STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.
Funakoshi-Tago M; Tago K; Abe M; Sonoda Y; Kasahara T
J Biol Chem; 2010 Feb; 285(8):5296-307. PubMed ID: 20028972
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol alleviates diabetes-induced testicular dysfunction by inhibiting oxidative stress and c-Jun N-terminal kinase signaling in rats.
Faid I; Al-Hussaini H; Kilarkaje N
Toxicol Appl Pharmacol; 2015 Dec; 289(3):482-94. PubMed ID: 26499206
[TBL] [Abstract][Full Text] [Related]
37. Thrombin-induced connective tissue growth factor expression in human lung fibroblasts requires the ASK1/JNK/AP-1 pathway.
Yu CC; Hsu MJ; Kuo ML; Chen RF; Chen MC; Bai KJ; Yu MC; Chen BC; Lin CH
J Immunol; 2009 Jun; 182(12):7916-27. PubMed ID: 19494316
[TBL] [Abstract][Full Text] [Related]
38. Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity.
Cooper SL; Sandhu H; Hussain A; Mee C; Maddock H
Toxicology; 2018 Feb; 394():72-83. PubMed ID: 29248607
[TBL] [Abstract][Full Text] [Related]
39. Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death.
Brandt B; Abou-Eladab EF; Tiedge M; Walzel H
Cell Death Dis; 2010; 1(2):e23. PubMed ID: 21364631
[TBL] [Abstract][Full Text] [Related]
40. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
